Related Experiment Video
Updated: Jun 23, 2026
28:15
Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer
Published on: July 28, 2010
Genetic and molecular abnormalities in cholangiocarcinogenesis
Victor J Hassid1, Frank A Orlando, Ziad T Awad
1Surgical Oncology Specialties, Cancer Center of Jacksonville, Jacksonville, FL 32256, USA.
Anticancer Research
|May 6, 2009
Summary
Cholangiocarcinomas, a type of biliary tree cancer, are increasingly studied for their molecular causes. Understanding these mechanisms could lead to new diagnostic and therapeutic targets for this poor-prognosis cancer.
Area of Science:
- Gastroenterology and Hepatology
- Oncology
- Molecular Biology
Background:
- Cholangiocarcinomas are cancers originating from the biliary tree's cholangiocytes.
- Clinical risk factors for cholangiocarcinogenesis are established.
- The poor prognosis and limited therapeutic options for cholangiocarcinoma necessitate research into its molecular underpinnings.
Purpose of the Study:
- To investigate the molecular mechanisms driving cholangiocarcinoma initiation, promotion, and progression.
- To explore the role of neurotransmitter, neuroendocrine, and endocrine factors in cholangiocarcinoma growth.
- To identify potential molecular targets for improved diagnosis and treatment of cholangiocarcinoma.
Main Methods:
- Review of current literature on cholangiocarcinoma molecular mechanisms.
- Analysis of signaling pathways involved in cholangiocyte neoplasia.
- Investigation of hormonal and neural influences on tumor development.
Main Results:
- Growing interest in molecular mechanisms due to poor prognosis and lack of effective therapies.
- Potential for understanding tumor initiation, promotion, and progression.
- Emerging evidence for neurotransmitter and endocrine influences.
Conclusions:
- A deeper understanding of cholangiocarcinoma's molecular biology is crucial.
- Identifying molecular targets could significantly improve diagnostic and therapeutic strategies.
- Further research into neuroendocrine and endocrine pathways may offer novel treatment avenues.
Related Concept Videos
01:25Mutagenicity and Carcinogenicity
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
02:59Cancer Prevention
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
01:33Cancer-Critical Genes I: Proto-oncogenes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...